银发经济或成下一个风口(共8份)
银发经济或成下一个风口
-
艾媒咨询|2021年中国夜间用药年度观察报告
本报告涉及的案例/品牌/企业:美团买药,叮当快药
在众多社会服务中,夜间用药成为人们最关注的夜间社会服务之一,近年来,各地相关行政管理机构也陆续出台相关扶持政策,鼓励商家上线夜间送药平台、发展24小时药店,提供夜间送药服务,推动解决“夜间买药难”问题。近日,iiMedia Research(艾媒咨询)最新发布《2021年中国夜间用药年度观察报告》,基于2021年初至2021年末的监测数据,对中国夜间用药市场持续追踪。报告显示,年初有61.2%的用户夜间生病选择忍,而年底这一数字降至52.1%,据推算年末夜间用药受益群体新增约4000万人。报告指出,日渐成熟的中国外卖送药平台,成为解决夜间用药的重要参与者。通过一年的发展,在美团买药“小黄灯”计划等24小时药店惠民工程的推动下,线上24小时药店数量增加、夜间买药配送速度更快、服务保障更加成熟,用户知晓度有了较大提升,夜间买药难的问题得到有效缓解。
Among many social services,night medication has become one of the night social services that people pay most attention to. In recent years,relevant administrative agencies around the country have also successively issued relevant support policies to encourage businesses to launch night medication delivery platforms,develop 24-hour pharmacies,provide night medication delivery services, and promote the solution of the problem of "difficulty in buying drugs at night". Recently, iiMedia Research released the annual observation report on nighttime medication in China in 2021,which continuously tracks China's nighttime medication market based on the monitoring data from the beginning of 2021 to the end of 2021. The report shows that at the beginning of the year, 61.2% of users chose to tolerate illness at night,while at the end of the year,the figure fell to 52.1%. It is estimated that about 40 million people will benefit from night medication at the end of the year.The report points out that the increasingly mature Chinese takeout delivery platform has become an important participant in solving the problem of night medication. Through one year's development,driven by the 24-hour pharmacy benefit project such as the "small yellow light" plan of meituan drug purchase, the number of online 24-hour pharmacies has increased,the speed of drug purchase and distribution at night is faster,the service guarantee is more mature,the user awareness has been greatly improved,and the problem of difficult drug purchase at night has been effectively alleviated. -
艾媒咨询|2021全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:阿里健康,美团,京东健康,叮当快药,1药网,Walgreens,百度健康,药材买卖网,中药材天地网,找药网,九州通,药易购,珍诚医药在线,CVS
在政策利好、互联网技术等多重因素推动下,中国医药电商行业规模持续快速发展,2020年中国医药电商市场交易规模达到1956亿元。当前,中药电商商业模式主要为B2B、B2C、O2O与DTP四种类型,其中,2020年,医药电商B2C模式占比近6%,市场规模为116亿元;医药电商B2C模式占比近84%,市场规模为1640亿元,成为当前的主流。此外,近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,而DTP药房模式下,患者在医院开取处方后,药房根据处方以患者或家属指定的时间和地点送药上门,被称为高值新特药直送平台。
Driven by favorable policies, Internet technology and other factors, the scale of China's pharmaceutical e-commerce industry continues to develop rapidly, with the transaction scale of China's pharmaceutical e-commerce market reaching 1956 billion yuan in 2020. At present, the business models of traditional Chinese medicine e-commerce are mainly B2B, B2C, o2o and DTP. In 2020, the B2C model of pharmaceutical e-commerce accounts for nearly 6% and the market scale is 11.6 billion yuan; the B2C model of pharmaceutical e-commerce accounts for nearly 84% and the market scale is 164 billion yuan, which has become the current mainstream. In addition, the o2o mode, which has sprung up in recent years, mainly achieves profits through "drainage transformation consumption feedback". In the DTP pharmacy mode, after patients get prescriptions in the hospital, the pharmacy delivers drugs to the door at the time and place designated by the patients or their families according to the prescriptions, which is known as the high value new special drugs direct delivery platform. -
艾媒咨询|2020年中国新经济独角兽&准独角兽TOP200榜单解读及标杆企业研究报告
本报告研究涉及企业/品牌/案例:丁香园、叮当快药、字节跳动、小象大鹅、小红书、豌豆公主、阿里云、蜜蜂科技-BEEPLUS、盒马网络、回收宝、商汤科技、珞石科技、猿辅导、编程猫。
在产业数字化及居民消费升级的推动下,新经济产业蓬勃发展,培育出多家独角兽及准独角兽企业。在2020年中国新经济独角兽及准独角兽两百强榜单中,分别有39.5%和42.0%的独角兽及准独角兽企业分布在华东地区,并有71.0%及75.0%的独角兽及准独角兽企业分布在北上广,体现出北上广作为超一线城市在培育独角兽企业上具有明显优势。iiMedia Research(艾媒咨询)数据显示,在两百强名单中,企业服务领域分布了20家独角兽企业及49家准独角兽企业,体现出在新经济发展环境下,各类崭新的商业模式和领域被挖掘,同时也存在更多市场主体对企业服务存在需求,也推动更多企业服务企业跻身独角兽/准独角兽行列。
Driven by the industrial digitalization and increasing consuming power, the new economy industry is growing rapidly, and cultivated lots of unicorn and quasi unicorn enterprises. In the 2020 China New Economy Unicorn and Quasi Unicorn Enterprise Top200 List, 39.5% and 42.0% of the unicorn and quasi unicorn enterprises are located in the eastern China respectively, while 71.0% and 75.0% are located in Beijing, Shanghai and Guangzhou, which showed that as super tier one cities, Beijing, Shanghai and Guangzhou have the clear advantage in terms of cultivating unicorn enterprises. As the data of iiMedia Research showed, within the Top200 list, there are 20 unicorn enterprises and 49 quasi unicorn enterprises in the field of enterprise service, which showed that under the growth of new economy, new types of business models and fields are discovered, and there are more market entities that have demand on enterprise services, which pushed more enterprise service enterprises into the ranks of unicorn/quasi unicorn. -
艾媒报告 |2019全球与中国医药电商市场与发展趋势研究报告
本报告研究涉及企业/品牌/案例:天猫医馆,七乐康,京卫大药房,阿里健康大药房,京东大药房,健客, 1药网,360好药,八百方,818医药网,CVS,Walgreens ,RiteAid ,开心人网上药店,药房网,药材买卖网,珍材网,中药材天地网,商康网,科欣医药,医药在线,我的医药网,药品交易网,药品终端网,药师帮,海王晨星,快方送药,药给力,搜药送,药急送,U医U药,叮当送药,健客网上药店,康爱多掌上药店,问药,好药师,111集团,中宏保险,医联,腾讯,仁和药业,浙江扁鹊,漱玉平民,华人健康,一树药业,德生堂
2019中国医药电商主要形成了B2C、B2B、O2O三种模式,B2C模式体量稳定在6%左右,规模呈增长趋势,预计2019年的市场交易额将达到554.6亿元;B2B模式下,西药类产品的需求比例较高,达87.1%,中药材、传统药品和第三方交易等都形成了专属B2B平台;而近几年兴起的O2O模式,主要通过“引流-转化-消费-反馈”等实现盈利,但区域覆盖度和消费者的信任度需要提高。iiMedia Research(艾媒咨询)大数据监测显示,目前1药网、健客网上药店、康爱多掌上药店的的综合实力排行较强。
2019 China's pharmaceutical e-commerce mainly formed three modes of B2C, B2B and O2O. The volume of B2C model is stable at around 6%, and the scale is increasing. It is expected that the market transaction volume in 2019 will reach 55.46 billion yuan; in B2B mode, western medicine The demand ratio of products is relatively high, reaching 87.1%. Chinese herbal medicines, traditional medicines and third-party transactions have formed a proprietary B2B platform. In recent years, the O2O model has emerged mainly through “drainage-conversion-consumption-feedback”. Achieve profitability, but regional coverage and consumer trust need to be improved. iiMedia Research (Ai Media Consulting) big data monitoring shows that the current comprehensive strength of 1 drug network, Jianke online pharmacy, Kang Aiduo pharmacy is strong.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告